Early study finds new lymphoma drug effective: Eighty percent of patients with a subset of lymphoma on a clinical trial saw their cancers shrink after taking zanubrutinib

In early research, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma.

Leave a Comment